StonvexLoading…
StonvexStonvexStonvexCore line items from INDO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.01M | $2.67M | $3.53M | $4.10M |
Operating Income | $-4.58M | $-5.93M | $-3.50M | $-4.60M |
Net Income | $-5.10M | $-6.34M | $-2.64M | $-3.06M |
EPS (Diluted) | $-0.35 | $-0.55 | $-0.26 | $-0.35 |
Total Assets | $22.76M | $21.91M | $17.72M | $20.57M |
Total Liabilities | $3.10M | $3.72M | $3.03M | $3.25M |
Cash & Equivalents | $0.00 | $0.00 | $0.00 | $0.00 |
Free Cash Flow OCF − CapEx | $-5.48M | Not available | Not available | $-3.21M |
Shares Outstanding | 14.99M | 13.60M | 10.14M | 10.14M |